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ABSTRACT 
 
Background.  Despite research aimed at understanding the mechanisms of essential 
hypertension, instances of this condition continue to rise. Recent findings indicate that the 
administration of dietary nitrates, in the form of beetroot juice and other nitrate-rich 
vegetables, may offer anti-hypertensive effects in various study populations.  
Objective.  This randomized, placebo-controlled, crossover trial sought to compare the 
effects of high-nitrate vegetable salads to the effects of low-nitrate canned vegetables on 
plasma nitrate/nitrite concentration, peripheral and central-aortic systolic and diastolic 
blood pressures, pulse wave velocity, and flow-mediated dilation. 
Methods.  Healthy, post-menopausal women (n=5; 80% Caucasian; 52.6 ± 5.7 years) 
with mildly elevated blood pressure (mean blood pressure ≥ 115/70 mm Hg and < 140/80 
mm Hg) were randomly assigned to ingest a fresh, high-nitrate vegetable salad or a low-
nitrate vegetable medley, twice per day, for a total of 10 consecutive days. Given the 
crossover design of the trial, participants observed a two to three week washout period 
followed by reassignment to the opposite condition. Findings were considered significant 
at a p-value < 0.05, and Wilcoxon Signed-Rank tests compared mean differences between 
conditions. 
Results. Plasma nitrate/nitrite concentration was significantly higher following 
consumption of the high-nitrate versus the low-nitrate condition (p = 0.043). Conversely, 
the differences in peripheral systolic and diastolic blood pressures were not statistically 
significant (p = 0.345 and p = 0.684 for systolic and diastolic pressures, respectively) nor 
were the differences in central-aortic systolic and diastolic blood pressures statistically 
significant (p = 0.225 and p = 0.465 for systolic and diastolic pressures, respectively). 
ii 
Similarly, when comparing the effects of the high-nitrate condition to the low-nitrate 
condition, the difference in pulse wave velocity was not statistically significant (p = 
0.465). Finally, flow-mediated dilation tended to improve following consumption of the 
high nitrate condition (p = 0.080). 
Conclusion. Twice daily consumption of a fresh, high-nitrate vegetable salad 
significantly increased plasma nitrate/nitrite concentration. Although the trial was 
underpowered, there was a trend for improved flow-mediated dilation. Finally, twice 
daily consumption of a fresh, high-nitrate vegetable salad did not significantly lower 
peripheral or central-aortic systolic or diastolic blood pressures or pulse wave velocity. 
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CHAPTER 1 
INTRODUCTION 
 
Problem 
Hypertension, or high blood pressure, is a major global health concern and in the 
U.S. alone, nearly one out of every three adults struggle with this largely preventable 
condition.1 Further, hypertension is linked to almost 1,000 deaths per day,1 and the CDC 
predicts that hypertension-related healthcare expenditures will exceed 270 billion dollars 
by 2030.2 Additionally, hypertension has been shown to increase the likelihood of 
chronic conditions including stroke, heart attack, coronary heart disease, heart failure, 
and kidney failure.3-5 Previous findings suggest that the prevalence of hypertension 
increases from early adulthood well into older adulthood.1 Next, research indicates that, 
on the basis of sex, there are notable differences between the onset of the condition. 
Specifically, when compared to similarly aged women, hypertension is more common in 
men 45 years of age or younger. Conversely, when compared with similarly aged men, 
the disease is reportedly more common in women 65 years of age or older.1,6 
To date, researchers have focused their efforts on identifying attainable strategies 
to prevent the development of hypertension by modifying certain lifestyle behaviors. One 
such behavior believed to be linked to hypertension is dietary intake. Numerous studies 
have focused on eliminating certain foods, which are believed to be responsible for 
increasing blood pressure, from one’s diet (e.g., foods high in sodium), while other 
studies have focused on consuming functional foods that may be responsible for lowering 
blood pressure.7-9  
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One functional food believed to lower blood pressure is beetroot juice (Beta 
vulgaris). However, studies that have utilized this nitrate-rich food source have been 
somewhat inconsistent, and have included a variety of study populations which may 
make interpretation of the findings somewhat difficult.9-14 Further, few studies have 
collectively assessed the effect of nitrate-rich whole foods on plasma nitrate/nitrite 
concentration, peripheral and central-aortic systolic and diastolic blood pressures, pulse 
wave velocity, and flow-mediated dilation.15,16  
Through the entero-salivary nitrate-nitrite-nitric oxide pathway, it has been shown 
that dietary nitrate is effective for improving endothelial function, and for lowering blood 
pressure in healthy adults.10,17 Given the high prevalence of, and economic burden 
associated with hypertension in the U.S.,1 it is vital to understand how nitrate-rich whole 
foods can be incorporated into an overall healthful lifestyle to combat this disease. Thus, 
findings from this study may be beneficial for designing appropriate lifestyle 
interventions to improve cardiovascular health in otherwise healthy, post-menopausal 
women (40-70 years old).  
 
Purpose of the Study 
The primary intent of this randomized, placebo-controlled, crossover trial was to compare 
the effects of a nitrate-rich vegetable salad to a low-nitrate vegetable medley, consumed 
twice per day, on plasma nitrate/nitrite concentration, peripheral and central-aortic 
systolic and diastolic blood pressures, pulse wave velocity, and flow-mediated dilation in 
healthy, post-menopausal women residing in Phoenix, Arizona. Beyond these parameters, 
height (in cm) and weight (in kg) were also assessed. 
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Research Aims and Hypotheses 
Study Aims: To compare the effects of a fresh nitrate-rich vegetable salad, consumed 
twice per day, to a canned low-nitrate vegetable medley, consumed twice per day on (1) 
plasma nitrate/nitrite concentration, (2) peripheral systolic and diastolic blood pressures, 
(3) central-aortic systolic and diastolic blood pressures, (4) pulse wave velocity, and (4) 
flow-mediated dilation in healthy, post-menopausal women residing in Phoenix, Arizona. 
Research Question 1: Is there a relationship between the consumption of a fresh nitrate-
rich vegetable salad, consumed twice per day, on plasma nitrates/nitrite concentration in 
healthy, post-menopausal women? 
Ha: Subjects will have a higher plasma nitrates/nitrite concentration following 
consumption of a fresh, nitrate-rich vegetable salad versus a canned vegetable 
medley twice per day. 
Research Question 2: Is there a relationship between the consumption of a fresh nitrate-
rich vegetable salad, consumed twice per day, on peripheral systolic and diastolic blood 
pressures in healthy, post-menopausal women?  
Ha: Subjects will have lower peripheral systolic and diastolic blood pressure 
following consumption of a fresh, nitrate-rich vegetable salad versus a canned 
vegetable medley twice per day. 
Research Question 3: Is there a relationship between the consumption of a fresh nitrate-
rich vegetable salad, consumed twice per day, on central-aortic systolic and diastolic 
blood pressure in healthy, post-menopausal women?  
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Ha: Subjects will have lower central-aortic systolic and diastolic blood pressure 
following consumption of a fresh, nitrate-rich vegetable salad versus a canned 
vegetable medley twice per day. 
Research Question 4: Is there a relationship between the consumption of a fresh nitrate-
rich vegetable salad, consumed twice per day, on pulse wave velocity in healthy, post-
menopausal women? 
Ha: Subjects will have lower (improved) pulse wave velocity following 
consumption of a fresh, nitrate-rich vegetable salad versus a canned vegetable 
medley twice per day. 
Research Question 5: Is there a relationship between the consumption of a fresh nitrate-
rich vegetable salad, consumed twice per day, on flow-mediated dilation in healthy, post-
menopausal women? 
Ha: Subjects will have higher (improved) flow-mediated dilation following 
consumption of a fresh, nitrate-rich vegetable salad versus a canned vegetable 
medley twice per day. 
 
Definition of Terms 
Cardiovascular diseases: disorders (e.g., stroke, coronary heart disease) affecting the 
heart and blood vessels. 
Diastolic blood pressure: pressure (mm Hg) recorded during the period of relaxation 
between heartbeats. 
Flow-mediated dilation: a measure of endothelial function used to evaluate 
cardiovascular disease risk.  
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Hypertension: elevated systolic and diastolic blood pressure, (≥ 140/90 mm Hg). 
Post-menopausal: a period of at least 12 consecutive months without menstruation.  
Pulse wave analysis: a technique used to generate a central waveform to determine 
central-aortic systolic and diastolic blood pressures.  
Pulse wave velocity: a technique used to assess arterial stiffness. 
Nitrate (NO3-): a nitrogen containing compound found primarily in green, leafy 
vegetables which may play a role in vasodilation once reduced to nitric oxide. 
Nitrite (NO2-): a nitrogen containing compound produced after the reduction of nitrates; 
nitrites may be further reduced to nitric oxide. 
Nitric oxide: a signaling molecule that promotes vasodilation of the arteries resulting in 
lower blood pressure.  
Systolic blood pressure: pressure (mm Hg) recorded while the heart is contracted.  
 
Delimitations and Limitations 
Delimitations of this study are healthy, post-menopausal women (40-70 years old) 
regardless of race/ethnicity, weight status, BMI classification, and socioeconomic status 
with blood pressure levels (≥ 115/70 mm Hg and < 140/80 mm Hg), subjects not taking 
hypertensive medication, alcoholic beverages, multi-vitamins, anti-histamines, 
decongestants, and antiseptic/antibacterial mouthwash. Findings from this study may not 
be applicable to other populations, or geographic regions. As with all research, 
limitations to this trial were inherent. One such limitation was that results were based on 
a small sample. Next, it was unknown whether salad greens used in the study were 
obtained from a single grower which may have led to differences in nitrate content. Yet 
6 
another limitation was that the nitrate levels of vegetables used in the study were not 
measured. 
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CHAPTER 2 
REVIEW OF LITERATURE 
 
Overview 
 Hypertension is a major global health concern, and in the U.S. alone, one out of 
three adults are afflicted with this largely preventable disease while another one in three 
adults have pre-hypertension, a condition in which blood pressure is higher than normal, 
but below the defined reference range.1,2,18 In 2013 alone, hypertension was determined 
to be the primary cause of, or a contributing factor to almost 1,000 deaths per day,1,2 and 
the CDC predicts that hypertension-related healthcare expenditures will exceed 270 
billion dollars by 2030.2 Next, hypertension appears to be a modifiable risk factor for 
other chronic health conditions including stroke, kidney disease, heart attack, and heart 
failure,1-4 and there appears to be a strong, positive correlation between blood pressure 
and these conditions even in situations where blood pressure levels are normal.4 
Additionally, elevated blood pressure appears to occur in early adulthood, and in the 
absence of adequate and consistent treatment, symptoms of this condition may become 
apparent in later stages of life.1 Thus, this review of literature focuses on five overarching 
goals. First, to briefly define hypertension and the major forms of the condition, to 
discuss mechanical factors influencing the condition, to explain the role of the nitric 
oxide pathway on blood pressure, to describe the role of dietary nitrates on blood 
pressure and other cardiovascular function tests, and finally, to discuss lifestyle factors 
that may influence the condition. 
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Hypertension 
Hypertension, or high blood pressure, is a condition in which the flow of blood 
through the arteries is greater than normal.19,20 Any recording of blood pressure will 
include both a systolic and a diastolic measurement. Systolic pressure pertains to the 
pressure against the arterial walls as the heart contracts while diastolic pressure pertains 
to the pressure against the arterial walls as the heart is at rest or between beats.19,20 While 
it is common for blood pressure to fluctuate times throughout the day (i.e., often 
increasing after exercise or during high stress situations),19 continuously elevated blood 
pressure levels may result in severe strain and/or damage to organs such as the heart and 
kidneys.20 Generally, a diagnosis of hypertension is made after the mean of two or more 
systolic blood pressure readings is at or above 140 mm Hg or after the mean of two or 
more diastolic blood pressure readings is at or above 90 mm Hg, during two or more 
subsequent visits to a physician.3 While hypertension may be linked to genetic pre-
dispositions including a mutation to the mitochondrially encoded tRNA isoleucine (MT-
TI) gene,3,21,22 environmental, dietary, and lifestyle factors play a significant role in 
reducing sub-optimal blood pressure levels, thereby attenuating the negative long-term 
effects of the condition.3 
Major Forms of Hypertension 
Primary and secondary hypertension are the two main forms of the condition; 
however, greater incidence is seen with primary hypertension.3,19,21 Primary hypertension 
occurs gradually, and in many cases, the true cause of this form of the condition is 
unknown.3 Conversely, secondary hypertension generally occurs as a result of one or 
more underlying health conditions such as obstructive sleep apnea, congenital defects 
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affecting the blood vessels, kidney complications, or chronic drug and/or alcohol use.21 
While secondary hypertension is often resolved once the underlying condition is under 
control, primary hypertension is a contributing factor to several chronic health conditions 
that may have devastating long-term health implications.3,4,19,21-23 
Prevalence of Hypertension 
Data from the 2009-2012 National Health and Nutrition Examination Survey 
(NHANES) indicated that approximately 33% or 80 million U.S. adults (≥ 20 years) have 
hypertension, and approximately 45% of those individuals reported that their 
hypertension was uncontrolled.1 Further, the prevalence of hypertension appears to vary 
by race, socioeconomic status, and state of residency.3,24,25 More specifically, the 
incidence of hypertension is generally higher among African Americans, individuals who 
report an annual household income of less than $43,000, and states in which greater than 
18.7% of residents live below the poverty line.25 
The Effect of Chronological Age and Sex on Hypertension 
With age, the human body undergoes notable cardiovascular and metabolic 
changes that may negatively impact health and wellbeing. Thus, it is not surprising that 
older individuals of either sex are at increased risk for the development of hypertension 
and other co-morbidities.26,27 In fact, when compared to individuals between 20-34 years 
of age, 67% of men and 78% of women over the age of 75 have hypertension. Next, 
women over the age of 65 are generally more likely to develop the condition while 
hypertension appears to be more common in men 45 years old or younger.2 Additionally, 
it is important to note that individuals between 18-39 years of age are generally less 
likely to seek medical guidance for their condition.28 Previous research has demonstrated 
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that, with advanced age, heart rate, pre- and after-load, and total cardiac output (the 
amount of blood the heart pumps per minute) generally declines both at rest and during 
physical activity.27 Likewise, advanced age generally presents with increased stiffening 
of the myocardium which increases the likelihood of higher than normal diastolic 
pressure and arterial wall stiffness – factors that may result in elevated arterial pressure.27 
Another consequence of advanced age and elevated blood pressure are 
disturbances in cognitive function. For example, increased systolic blood pressure, in 
otherwise healthy older adults, has been associated with damage to the brain which may 
negatively impact cognitive performance in older populations.29-32 A cohort study 
conducted on over 900 subjects with high blood pressure (aged 65 or older) and no 
known history of cognitive impairment revealed that the presence of hypertension 
significantly increased the risk of cognitive impairment specific to language, visual-
spatial function, and lapses in memory.31 Similarly, a cross-sectional trial conducted on 
over 6,000 subjects (aged 60 and older) from the NHANES III indicated that normal 
blood pressure was associated with better cognitive performance while the presence of 
elevated blood pressure, overt hypertension, or even uncontrolled blood pressure was 
linked to lower levels of cognitive function in subjects 70 years or older.30 
The Effect of Ovarian Age on Cardiovascular Diseases 
 In addition to changes observed during the aging process, several age-related 
ovarian changes occurring in women have been shown to influence blood pressure.26 For 
instance, the onset of menopause presents with pronounced changes in body fat 
distribution – namely, from a gynoid to an android pattern. Additionally, with the loss of 
estrogen, a largely protective hormone, post-menopausal women commonly experience 
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reduced glucose tolerance, high concentrations of triglycerides and lipoprotein(a), low 
concentrations of high density lipoprotein (HDL), and increased vascular inflammation 
and endothelial dysfunction – factors which have been shown to be especially impactful 
for blood pressure control in women.26,33,34 Additionally, findings from a clinical trial 
indicated that early post-menopausal women undergoing hormone replacement therapy 
(HRT) saw protective cardiovascular outcomes when compared to women assigned to the 
control group (oral calcium). Further, subjects assigned to the control group gained 
significantly more weight, total body fat mass, and an overall increase in trunk, arm and 
leg fat while subjects in the intervention group developed no significant changes in these 
parameters, except for a significant increase in leg fat.33 
 Similarly, when compared to men of similar ages, post-menopausal women 
appeared to have a higher overall risk for cardiovascular diseases.26 More specifically, 
findings from the Framingham Heart Study showed that, after a 30-year follow-up, the 
incidence of cardiovascular diseases in subjects 35-64 years old age were higher in 
women than in men.35 Next, after adjustments were made for age, BMI, and tobacco use, 
diabetic and hypertensive women had greater mortality-related cardiovascular disease 
risk than men.26,36 More alarmingly, in the presence of both diabetes and hypertension, 
the mortality risk factor increased nearly twofold over that of men.26,36  
Hypertension and Cardiovascular Diseases 
 A report released by the World Health Organization states that, among older 
adults, cardiovascular diseases are the leading cause of death both globally and 
nationally.37 In fact, in 2012 alone, approximately 17.5 million U.S. deaths were 
attributable to various cardiovascular diseases, and globally, coronary heart disease was 
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responsible for an estimated 7.4 million deaths, while strokes claimed the lives of nearly 
6.7 million individuals.37 To date, hypertension has been implicated as a major 
contributing factor in the development of these chronic cardiovascular and renal 
conditions.3-5 In fact, hypertension is the most significant risk factor for all forms of 
strokes,38,39 and epidemiological studies dating back to as early as 1970 suggest that, in 
instances of controlled hypertension, subjects can expect a dramatic reduction in all-cause 
stroke mortality.39,40 On the contrary, when compared with normotensive individuals, 
those with isolated systolic hypertension tend to experience approximately two to four 
times as many strokes. Further, a prospective study conducted on over 500 older 
individuals with hypertension indicated that morning systolic pressure was the strongest 
predictor of stroke.41 
Given that the kidneys are crucial in the determination of blood pressure, the 
association between hypertension and kidney disease remains a matter of considerable 
interest in the health community.42 It has been established that elevated blood pressure is 
deleterious to kidney function.42,43 Further, it has been shown that systolic, rather than 
diastolic pressure, is a greater threat to the progression of kidney disease.43   
Mechanical Factors Affecting Blood Pressure 
Within the human body, blood pressure is tightly regulated by several complex 
mechanisms which involve the heart, kidneys, blood, and blood vessels.4 Together, these 
mechanisms work to ensure that blood pressure remains within a designated range. 
However, prolonged stress and/or assault to these mechanisms may result in long-term 
structural and functional damage which may negatively impact cardiovascular health and 
mortality over time.3 
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Endothelial Function  
The endothelium is a large, endocrine organ that functions to promote vascular 
homeostasis.44,45 The dynamic endothelium lines both lymphatic and blood vessels 
including capillaries, arteries, and veins.46 The location of endothelial cells allows for 
direct contact between lymph, blood, and circulating cells within the body. As such, these 
highly specialized cells function as protective barriers to control vascular tone and blood 
fluidity, thereby regulating blood pressure.46 However, in instances of prolonged elevated 
blood pressure, endothelial cells become damaged as a result of excessive inflammation. 
This occurrence, commonly referred to as endothelial dysfunction, results in the eventual 
development of atherosclerosis, a disease in which plaque (a combination of fatty waste 
products, cholesterol, and other substances present in the blood) proliferates, remodeling 
of blood vessels occurs, and synthesis of protective endothelial factors such as nitric 
oxide diminishes. Collectively, these factors greatly exacerbate the onset and progression 
of hypertension.44-46 
Flow-mediated Dilation 
Endothelial dysfunction, a noteable risk factor for the development of 
athlerosclerosis, is present even before overt damage is observed.46-49 However, traditional 
measures of endothelial function, such as infusing acetylcoline into target arteries have 
been invasive and impractical for clinical practice.48,50 Conversely, since its inception in 
1992, the use of flow-mediated dilation, a non-invasive procedure, has become the most 
commonly utilized technique to measure endothelium-dependent vasodilator function in 
humans.45,49,51,52 A study conducted to test the validity of flow-mediated dilation as an 
indicator of vascular function indicated that the intra-rater variability was 2.9% for brachial 
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diameter and 1.4% for hyperemic responses.47 Flow-mediated dilation values are obtained 
by high-resolution ultrasonography and are computed as an index of vascular function.45 
During a flow-mediated dilation procedure, the diameter of the brachial artery is measured 
in response to intentional hyperemia.48 This increase in sheer stress, assessed after a period 
of occlusion, induces increased blood flow to the area thereby prompting the release of 
endothelial-derived nitric oxide. This increase in nitric oxide triggers a vasodilatory 
response in the target artery.45,48 It has been demonstrated that factors such as exercise, 
temperature, drugs, and certain foods can affect flow-mediated dilation measurements. As 
such, it is recommended that subjects undergoing this procedure fast for at least eight hours 
prior to examination, and that all assessments be completed in a temperature-controlled 
environment free of noise. Further, given that vasoactive medications may impact flow-
mediated dilation measurements, it is best for subjects to refrain from use for at least four 
half-lives of the medication.45 In healthy subjects, flow-mediated dilation values are 
generally 7-10% of subjects’ baseline diameter, however; subjects with cardiovascular 
diseases tend to have values between 0-5% of their baseline diameter.49 
Studies which have compared flow-mediated dilation values in healthy individuals 
versus those with atherosclerosis have found that flow-mediated dilation values were 
depressed in subjects with atherosclerosis, and other coronary risk factors.49 Next, flow-
mediated dilation values were generally higher in pre-menopausal women and lower in 
older individuals.49,53 Specifically, linear regression models conducted on subjects from the 
Framingham Heart Study indicated that flow-mediated dilation values were positively 
associated with heart rate and female sex while there was an inverse association specific to 
age, systolic blood pressure, and BMI.53 However, it should be noted that, even in healthy 
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subjects, advanced age appears to have a profound impact on flow-mediated dilation 
values.54,55 In fact, a comparison between younger subjects (26.5 +/- 7.2 years old) and 
elderly subjects (71.3 +/- 5.8 years old), all of whom were reported free of major 
cardiovascular risk factors, revealed that younger subjects had significantly higher flow-
mediated dilation values.54 Similarly, findings from a recent publication indicated that, for 
both sexes, flow-mediated dilation values decreased significantly with age. For instance, 
men experienced a steady decline in flow-mediated dilation after the age of 30 while 
women experienced the steepest decline after the age of 45.55 
Considering that flow-mediated dilation measurements are instrumental in 
capturing cardiovascular responses to both short- and long-term events, it is now regarded 
as an excellent assessment tool to determine endothelial function following nutrition or 
physical activity interventions.49,56 A crossover investigation conducted on 24 relatively 
healthy subjects to compare the effects of olive oil versus walnut consumption indicated 
that subjects who ingested walnuts saw a significant increase in flow-mediated dilation 
values over subjects who ingested olive oil.56 
Pulse Wave Analysis 
 In humans, the pulse is an important signal of cardiovascular health.57 Each pulse 
originates at the heart and then migrates to the blood vessels.57,58 As each pulse travels to 
the blood vessels, reflections may occur at any level within the vessel walls.57 Several 
conditions play a role in the rate and/or rhythm of a pulse including the elasticity of blood 
vessel walls, the viscosity of blood, and the resistance of blood flow.57 These physiologic 
changes may influence the reflection of a pulse and/or the strength or frequency of a 
pulse.57 While there are numerous techniques used to assess the human pulse, the use of 
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pulse wave analysis has been longstanding given that these measurements provide valuable 
information on the cardiovascular system57 including early detection of arterial stiffness, 
and the onset and progression of hypertension.59  
 Researchers agree that, independent of blood pressure, arterial stiffness is an 
important indicator of sub-optimal central-aortic systolic blood pressure, even during early 
stages of hypertension when symptoms of the disease are not yet present.44,60,61 With each 
heartbeat, arteries transport oxygenated blood and other nutrients to the rest of the body 
including the brain and other vital organs. Given the importance of these transport vessels, 
it is crucial to understand which factors negatively impact healthy arteries. These factors 
may include prolonged stress, chronological age,60 and structural damage to the arteries as 
a result of unhealthful lifestyle behaviors including tobacco use or other disease states.44 
While healthy arteries are highly elastic and capable of expanding to withstand increased 
blood flow, unhealthy arteries gradually lose their elasticity, and become stiffer and less 
pliable over time.44,60 
 A randomized, crossover study conducted on 19 healthy subjects to assess the 
effects of acute mental stress on arterial stiffness indicated that mental stress was positively 
associated with sustained increases to central-aortic systolic pressure, pulse pressure, and 
stiffness of the aortic artery.62 In another study employing similar methods, laughter was 
shown to decrease arterial stiffness, while acute stress was shown to have the opposite 
effect.63 
Next, a study conducted on almost 3000 subjects indicated that there was an 
increased risk of heart disease and stroke in the presence of stiffer arteries.64 Similarly, 
when researchers assessed the relationship between arterial stiffness and organ damage in 
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almost 200 subjects with hypertension, arterial stiffness was positively associated with  
organ damage, as indicated by increased triglycerides, 24-hour pulse pressure, and 24-hour 
systolic pressure.65 Finally, a study conducted on over 500 hypertensive subjects who were 
classified as current-, ex-, or non-smokers revealed that, when compared to non-smoking 
subjects, current and ex-smokers had a significantly higher level of arterial stiffness.66 
Pulse Wave Velocity 
As previously indicated, hypertension develops as a result of prolonged stiffness 
within the arterial walls, and researchers agree that arterial stiffness is an important and 
independent contributor of all-cause cardiovascular risk.67-70 Currenty, there are several 
laboratory assessments that may be used to assess the level of stiffness within the arterial 
walls. However, of these indices, pulse wave velocity of the cartoid-femoral artery is 
regarded as the gold standard because of its ease of use, reliabilty, and the growing body of 
evidence that has demonstrated a clear association between pulse wave velocity 
measurements and cardiovascular disease risk.67,69-71 It should be noted that, prior to the 
past five years, utilization of this non-invasive technique has been largely hindered due to a 
lack of established reference ranges.67 However, following a landmark study conducted on 
almost 17,000 subjects with various blood pressure ranges, and/or cardiovascular risk 
factors such as smoking and dyslipidemia, reference ranges were established based on 
several different methodologies and equations, and were provided for populations of 
various age ranges, and health parameters.67 Unlike flow-mediated dilation parameters, 
lower pulse wave velocity values suggest less arterial stiffness and increased cardiovascular 
health. For example, for healthy individuals under the age of 30, optimal pulse wave 
velocity was recorded at 6.1 m/s (4.6–7.5; 2 SD). Conversely, with increasing age, optimal 
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pulse wave velocity tended to increase, but the overall goal is to maintain these values as 
low as possible.67 
Given these standards, the assessment of pulse wave velocity has been used to 
better understand how arterial stiffness relates to the development of cardiovascular 
diseases, and as previously indicated, a higher pulse wave velocity index is associated with 
a higher level of arterial stiffness and increased cardiovascular risk.72,73 Findings from a 
cross-sectional study showed that, among nearly 400 post-menopausal women between the 
ages of 50 and 74, the presence of arterial stiffness was positively associated with BMI, 
type 2 diabetes, fasting glucose levels, and triglycerides. As such, the risk of heart disease, 
stroke, and death were higher among subjects with higher pulse wave velocity scores.72 
Similarly, advanced age appears to be a major determinant of pulse wave velocity 
values, and independent of blood pressure level, this occurrence is especially true in 
women.73-75 A study conducted on over 200 pre- and post-menopausal women 
demonstrated that there were significant differences between global pulse wave velocity 
when comparing pre- and post-menopausal women. More specifically, post-menopausal 
women had higher global pulse wave velocity values when compared to pre-menopausal 
women. Next, similar differences were observed in pre-menopausal women who were 
normotensive versus those who were hypertensive, where pre-menopausal women who 
were normotensive had lower global pulse wave velocity values when compared to pre-
menopausal women who were hypertensive.75  
In another study conducted on post-menopausal women, investigators utilized a 
pulsed doppler global pulse wave velocity technique to assess the relationship between 
aortic stiffness and cardiovascular risk in nearly 300 subjects. Here, subjects were 
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categorized by diabetes, hypertension, hypercholesterolemia, or any combination of these 
conditions.74 Findings from this trial revealed that a combination of all three conditions was 
the significant determinant for a higher global pulse wave velocity index over single 
diagnoses. These findings further support the association between aortic stiffness and 
cardiovascular risk factors in post-menopausal women.74  
Nitric Oxide 
Nitric oxide, synthesized by endothelial cells from the precursor L-arginine, is a 
signaling molecule that plays an important role in regulating the cardiovascular system as 
well as the nervous and immune systems.76,77 Specific to the cardiovascular system, nitric 
oxide has long been recognized as a key regulatory molecule that influences resting 
vascular tone, vasodilation of arterial walls, platelet adhesion, regeneration of endothelial 
tissue, and inhibition of white blood cells, when necessary.77,78  
Generally speaking, individuals with hypertension exhibit marked increases in 
vascular tone and reduced vasodilation of large, conduit arteries.23,78 This continued form 
of vessel damage may result in vascular remodeling that limits the bioavailability and 
bioactivity of nitric oxide.78 A previous investigation indicated that nitric oxide synthesis is 
diminished even in early stages of primary hypertension, and that diminished nitric oxide 
synthesis is also detectable in young, normotensive offspring of subjects with 
hypertension.79 However, it should be noted that there is no direct evidence to suggest that 
offspring of hypertensive subjects experience higher blood pressure as a result of 
diminished nitric oxide synthesis.79  
Additionally, it is also important to recognize that nitric oxide-promoting anions 
such as organic nitrates and nitrites may be diminished in hypertensive environments and 
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that smooth muscles may become insensitive to circulating nitric oxide.80,81 A study 
conducted to examine the relationship between various stages of essential hypertension and 
plasma nitrate and nitrite concentrations reported that, when compared to subjects in the 
control group, subjects with hypertension have significantly lower levels of plasma nitrates, 
nitrites, and nitric oxide. Further, there was a significant, inverse relationship between nitric 
oxide concentrations and systolic and diastolic blood pressure levels.23 
Regulation of the Nitric Oxide Pathway 
 Historically, nitrates and nitrites were regarded as inactive derivatives of nitric 
oxide metabolism with potentially cancer-causing effects.17 However, investigations 
conducted during the past ten years oppose this position, and argue that these inorganic 
anions are, in fact, beneficial to the human body.17 More specifically, studies have shown 
that nitrates and nitrites may be recycled in the blood and tissues to upregulate nitric oxide 
synthesis in oxygen-deficient situations.17,82,83 Given the ability of these anions to stimulate 
nitric oxide bioactivity, it is essential to further investigate the mechanisms by which these 
anions protect against nitric oxide-regulated health conditions such as hypertension.17 
 Following the reduction of dietary nitrates to nitrites, various pathways, including 
the L-arginine-NOS pathway and the nitrate-nitrite-nitric oxide pathway may be present to 
further reduce nitrites to nitric oxide. However, during instances of reduced oxygen 
availability, a condition known as hypoxia, the L-arginine-NOS pathway is down-regulated 
while the nitritate-nitrite-nitric oxide pathway becomes the primary means by which nitric 
oxide is produced. Thus, in instances of hypoxia, the production of nitric oxide is 
significantly enhanced to aid in vasodilation, and the regulation of cellular 
respiration.17,84,85  
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Bacteria Needed for the Nitric Oxide Pathway   
 To initiate the process of nitric oxide production via the nitrate-nitrite-nitric oxide 
pathway, dietary nitrate must first undergo an initial reduction to nitrite via commensal 
bacteria present in the mouth. Facultative anaerobic bacteria is necessary because humans 
lack the necessary reductase enzymes to reduce nitrate to nitrite.17,86 Following 
consumption, dietary nitrate undergoes rapid absorption in the upper gastrointestinal tract. 
From here, the salivary glands extract up to 25% of circulating nitrate which is then 
concentrated in the saliva. Next, facultative anaerobic bacteria in the oral cavity reduces 
nitrate to nitrite via the action of nitrate reductase enzymes present in the bacteria. Once the 
nitrite-rich saliva is swallowed and reaches the stomach, the nitrite present in the system is 
converted to nitrous acid which further decomposes to form nitric oxide.86-88 
Role of Nitrates in Hypertension 
 Nitrates are an important form of naturally occuring nitrogen that is of particular 
importance to the nitrogen cycle.87 In healthy individuals, normal plasma levels of nitrates 
range from 20-40 μM/L while nitrite concentrations are significantly less and range from 
50-300 nM/L.17,88 Further, plasma levels of both nitrates and nitrites increase substantially 
in the presence of inflammatory diseases.17 However, in instances of endothelial 
dysfunction, such as the case in hypertension, levels of both anions remain low.88 For 
instance, when compared to baseline levels of nitrites, there appears to be a progressive and 
significant decline in nitrite levels as cardiovascular risk increases. Similarly, when 
compared to healthy individuals, those with endothelial dysfunction experience lower 
levels of flow-mediated dilation and plasma nitrite as these two factors are positively and 
significantly correlated.88 Next, emerging evidence indicate that foods high in inorganic 
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nitrates may be beneficial for various measurements of cardiovascular function including 
the ability to reduce blood pressure, improve endothelial function, and reduce 
dislipidemia.71 Thus, increasing the consumption of high-nitrate foods may very well 
prevent or reduce the likelihood of developing other cardiovascular diseases.15,71,89 More 
importantly, increased consumption of high-nitrate vegetables and low-fat dairy products 
may be effective for lowering blood pressure to a similar extent as single-class 
hypertension medications.92 
How Nitrates Protect Against Hypertension  
As previously indicated, nitrates were regarded as undesirable byproducts of nitric 
oxide metabolism.17,93 However, recent data have demonstrated the importance of dietary 
inorganic nitrates to guard against hypertension in several study populations. The 
mechanism by which nitrates may prevent hypertension is via the upregulation of nitric 
oxide synthesis. An increase in nitric oxide synthesis is important to allow the arteries to 
dilate during periods of sheer stress resulting in decreased blood pressure, and improved 
overall cardiovascular function.17,91,93 In order for dietary nitrates to be used as a part of the 
nitric oxide pathway to promote vasodilation of the arterial walls, this important anion must 
first be reduced to nitrite within the body.   
Given that humans lack the specific reductase enzymes to effectively convert 
nitrates to nitrites, a commensal facultative anaerobic bacteria located in the upper 
gastrointestinal tract and in the oral cavity is required to successfully reduce nitrate to 
nitrite.17,93 Once this conversion occurs, nitrites are eventually reduced to nitric oxide via 
several mechanisms. Additionally, in instances of hypoxia and increased acidosis, the 
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synthesis of nitric oxide is greatly enhanced to ensure that the body maintains normal 
functioning.17,93 
 To date, numerous trials have indicated that upregulating nitric oxide, either 
through endogenous means or via the administration of nitric oxide precursors, is effective 
to increase nitric oxide production and subsequently decrease blood pressure.78,94-96 In one 
trial, exogenous L-arginine, a precursor of nitric oxide, was administered intravenously to 
subjects with primary and secondary hypertension. Following administration, subjects’ 
blood pressure, heart rate, cardiac output, and several other functional markers were 
assessed. Findings from this investigation showed that nitric oxide increased following 
administration of L-arginine, and mean arterial blood pressure and peripheral resistance 
decreased while cardiac output and heart rate increased.94 Next, a crossover trial assessing 
the intake of supplementary beetroot juice administered to healthy young subjects 
demonstrated a significant reduction of approximately 4% in both systolic and diastolic 
blood pressure, which was maintained for roughly two weeks with continued 
administration of the intervention.95 In other studies, ingestion of high-nitrate food or 
beverage items resulted in increased bioactivation of nitric oxide which led to 
vasoprotective outcomes in as little as three hours after ingestion.95,97 Further, ingestion of a 
high-nitrate meal has been shown effective for preventing acute endothelial dysfunction, 
measured by purposefully inducing an ischemic assault to the forearm.97 
Nitrate-Rich Foods 
 Dietary constituents that are notably high in nitrates include green, leafy vegetables 
such as spinach, arugula, celery, and lettuce; root vegetables such as red beetroot, turnip, 
and radish; and herbs such as parsley, and fennel.71,91 In addition to vegetables and select 
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fruits, nitrates are naturally-occurring in the human body, and may even be formed via a 
combination of fertilizers, manure, and plant remains.89,91 As such, high concentrations of 
nitrates may be present in the air, soil, plant fertilizer, and water. Additionally, nitrates have 
been historically used as a preservative to prevent microbial growth and spoilage, and are 
generally found in raw and processed meats including hot dogs, bacon, select cheeses, and 
some alcoholic beverages.89  
In spite of the origin of nitrates, there is considerable variability in nitrate content 
among foods.91 Specific to vegetables, much of this variability is attributable to light 
exposure and the amount of nitrogen present in the fertilizer used before or during 
harvest.98,99 For instance, a convenience study which assessed the nitrate content of various 
fruits and vegetables found that spinach showed the highest concentration of nitrates 
followed by mustard greens. Conversely, fruits including bananas and oranges exhibited 
the lowest concentation of nitrates. Aside from the sample of fruits, vegetables, and select 
cured meats assessed in the study, a commercially-prepared vegetable supplement showed 
the highest concentration of nitrates.91 
Studies that have explored the effects of high-nitrate foods on cardiovascular 
function have shown promise in various study populations.71,91 For instance, a 3-day 
randomized, placebo controlled crossover study which assessed the effects of a high nitrate 
diet supplement on blood pressure in healthy, physically active young adults demonstrated 
decreased levels of diastolic blood pressure following ingestion of the nitrate supplement.12 
Further, findings from this study were similar to that of the well-known DASH trial.100 In 
another randomized crossover study, which sought to assess the short-term effects of green 
leafy vegetables on blood pressure and arterial stiffness in a sample of subjects with high-
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normal blood pressure (120 to 139 mm Hg), subjects who consumed the high-nitrate 
intervention for seven days had significantly increased salivary and plasma nitrate/nitrite 
concentration when compared to subjects who consumed the low-nitrate intervention. 
However, no significant findings were reported for ambulatory or home blood pressure 
measurements or for indices of arterial stiffness in this sample population.71 
Bioavailability of Nitrates  
 Roughly 80-85% of all nitrates consumed are in the form of vegetables.101 Further, 
following ingestion, the absorption rate of dietary nitrates is relatively quick and 
approximately 20-28% of the ingested load is secreted into the saliva.101,102 Additionally, 
several sources report that the bioavailability of nitrates is approximately 100% regardless 
of the form consumed (e.g., cooked versus uncooked varieties).91,101 A recent crossover 
trial, which assessed plasma levels of nitrates following ingestion of cooked spinach, raw 
lettuce and cooked beetroot, indicated that the bioavailability of nitrates was similar across 
the three treatment groups. That is, the absolute bioavailibility of nitrates was 98 +/- 12% 
and 106 +/- 15% from cooked spinach and cooked beetroot, respectively, while the 
absolute bioavailability of nitrates from raw lettuce was 114 +/- 14%.101 
Nitrate Contraindicators  
In spite of the high biovailability of nitrates,101 there are several agents that limit or 
altogether inhibit the ability for nitrates to be converted to nitrite, and eventually to the 
vasodilator, nitric oxide.103-105 One such contraindicator is strong mouthwash solutions. 
While the use of mouthwash agents have been recommended to reduce and/or to treat 
halitosis and to enhance oral health, the use of strong antibacterial mouthwash solutions 
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may be potentially harmful to cardiovascular health due to the fact that these solutions limit 
the bioavailability of nitric oxide by impairing the nitrate-nitrite-nitric oxide pathway.103  
Recently, a randomized study, which sought to examine the effects of three 
different strengths of mouthwash solutions on salivary and plasma nitrate concentrations in 
healthy, normotensive individuals indicated that the administration of Listerine mouthwash 
(an antiseptic agent) had no discernable effect on the conversion of nitrates to nitrites. This 
is perhaps due to the fact that the solution contained a relatively low amount of 
antibacterial agents to actually impact the bacteria present in the mouth and saliva. 
Conversely, there appeared to be a greater effect of the antibacterial mouthwash solution, 
and chlorhexidine mouth rinse. Specifically, the antibacterial agent appeared to limit the 
conversion of plasma nitrates to nitrites, while the chlorhexidine rinse altogether inhibited 
the conversion of plasma nitrates to nitrites.103  
Other trials utilizing similar study designs have reported comparable results.104,105 
For instance, a study assessing the effects of weak versus strong antibacterial mouthwash 
agents reported that, following ingestion of a nitrate treatment in healthy adults, both agents 
were effective for reducing the rise of plasma nitrites. Further, use of the strong mouthwash 
solution appeared to increase mean systolic blood pressure during a low-intensity treadmill 
test conducted four hours following ingestion of the nitrate load.104 Another study 
conducted on older subjects with hypertension (mean age of 65) indicated that relative to 
the control group, subjects who used the antibacterial mouthwash exhibited a decreased 
ability to convert nitrates to nitrites, and showed higher systolic blood pressure levels 
following the 3-day intervention period.105  
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Another factor that has been shown to impact nitric oxide regulation is ethanol, an 
active ingredient present in beverages including beers, wines, and strong liquors. Early 
animal studies revealed that nitric oxide synthesis may be limited by the consumption of 
ethanol.106 However, in human trials, the effects of ethanol on the endothelium may be 
somewhat more complex. Specifically, low-dose ethanol consumption appears to have 
favorable effects on endothelial function by upregulating nitric oxide production. 
Conversely, high-dose ethanol exposure appears to have a negative effect on endothelial 
function by reducing nitric oxide production.107,108 
Lifestyle Factors Affecting Blood Pressure 
A report published by the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure declared that the risk of developing 
cardiovascular diseases begins at a systolic blood pressure of 115 mm Hg and a diastolic 
blood pressure of 75 mm Hg. Further, risk appears to increase twofold with each 20/10 mm 
Hg increase in blood pressure.109 The report further indicated that normotensive 
individuals, aged 55 years old, have a 90% risk of developing hypertension over their 
lifetime, and that efforts should be made to promote lifestyle initiatives to treat and prevent 
the development of this chronic condition.109 Additionally, maintaining a 12 mm Hg 
decrease in systolic blood pressure for a period of ten years may be effective for preventing 
one out of eleven deaths in patients treated with hypertension.109 To date, notable factors 
that have been shown to influence blood pressure are exercise, anti-inflammatory agents, 
and diet.109-114  
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The Effects of Exercise on Blood Pressure 
 Prolonged inactivity has been positively associated with increased risk of 
hypertension and other chronic conditions including obesity, type 2 diabetes, as well as 
joint and bone diseases,113,114 and these findings have been consistent among various study 
populations. Thus, physical inactivity has long been regarded as a modifiable risk factor for 
these chronic conditions,110,114 and studies which have assessed the effects of physical 
activity on the risk of death from cardiovascular diseases have noted that continuous 
involvement in physical activity is associated with greater than 50% risk reduction.112 
Further, individuals who increased their energy expenditure (of up to 1000 kcal per week) 
through physical activity involvement showed a 20% reduction in mortality risk.111 
Conversely, middle-aged women who reported high levels of sedentary behavior (defined 
as less than one hour of physical activity per week) exhibited a twofold increase in risk for 
cardiovascular diseases, including hypertension, and a 52% increase in all-cause mortality 
risk.111 
Considering that low levels of cardiorespiratory fitness are associated with both all-
cause mortality risk and risk for cardiovascular diseases, researchers have taken a keen 
interest in understanding the role that physical activity plays in improving cardiovascular 
fitness and reducing overall mortality risk.114-117 In a randomized, controlled trial of 
roughly 150 overweight or obese subjects with pre-hypertension or stage I hypertension, 
regular involvement in physical activity resulted in significant reductions in both clinical 
and ambulatory blood pressure (approximately 16.1/9.9 mm Hg reduction). Furthermore, 
subjects developed significant improvements in pulse wave velocity and other 
cardivascular function measures.115 Meta-analyses conducted on both aerobic exercise and 
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resistance training routines indicate that both forms of physical activity have been shown to 
be effective for reducing blood pressure in various study populations. However, of the two 
forms of activity, there is considerably more evidence to support the role of aerobic 
exercise in blood pressure reduction.116,117 
The Effects of Anti-inflammatory Agents on Blood Pressure  
 In an effort to relieve pain and discomfort associated with acute and chronic 
illnesses, the use of anti-inflammatory agents have become a common treatment option. 
However, a growing body of evidence suggests that certain anti-inflammatory agents may 
actually promote the onset of diseases such as hypertension, myocardial infarction, heart 
failure, and stroke.118,119 For example, in 2004, the drug Rofecoxib (Vioxx), generally 
prescribed to relieve pain associated with osteoarthritis, was shown to increase the risk of 
cardiovascular events, and was subsequently withdrawn from wordwide use. Later that 
same year, the US Food and Drug Administration (FDA) issued a warning for valdecoxib 
(Bextra), a drug used to relieve painful menstruation cramps and various forms of arthritis, 
given that use of this drug was contraindicated in individuals undergoing coronary bypass 
graft surgery. Similarly, the National Institutes of Health (NIH) suspended the use of 
celecoxib (Celebrex), a drug that inhibits inflammatory hormones that are present during 
menstruation and arthritis, as it was also linked to increased risk of cardiovascular 
events.119 
 Additionally, oral anti-inflammatory agents such as pseudoephedrine are commonly 
used to treat symptoms associated with rhinitis and rhinorrhea. To date, many over-the-
counter and prescription decongestants include pseudoephedrine. Examples include 
Allegra-D, AlkaSeltzer Plus Cold Medicine, Aleve Cold and Sinus Caplets, Claritin-D 24-
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hour Tablets, Benadryl Allery and Sinus Tablets, and Sudafed 24-hour Tablets.120 A review 
article published in 2005 aimed at understanding the effects of pseudoephedrine use on 
blood pressure and heart rate yielded interesting results.120 First, there appeared to be a 
small, but significant increase in systolic blood pressure and heart rate following the use of 
agents containing pseudoephedrine. Next, immediate-release of pseudoephedrine appeared 
to significantly elevate systolic blood pressure while sustained-release of the agent showed 
no significant effect. Conversely, heart rate appeared to increase significantly following 
both immediate-release and extended-release formulations. Finally, higher doses of 
pseudoephedrine were linked to substantial elevations of both systolic and diastolic blood 
pressure and subjects with stable, treated hypertension experienced increased systolic blood 
pressure, but no effect on heart rate and diastolic blood pressure as a result of 
pseudoephedrine therapy.120 
 Given the link between the use of anti-inflammatory agents and the risk for 
cardiovascular events, the American Heart Association (AHA) issued a statement to guide 
clinicians on how to best balance the risks and benefits associated with the use of these 
agents. AHA’s statement indicates that individiuals with prior history of cardiovascular 
diseases, or those with prior risk for these diseases are at greatest risk for adverse effects of 
anti-inflammatory agents. Further, for these at-risk individuals, anti-inflammatory agents 
should only be prescribed in the event that no alternative medications exist. Finally, the 
AHA recommmends that the lowest dose of anti-inflammatory medications be prescribed 
for the least amount of time.119 
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Dietary Factors Affecting Blood Pressure 
 A growing body of evidence has focused on the relationship between diet and blood 
pressure, and given that progressive elevations in blood pressure are associated with the 
onset of hypertension,7 it is becoming clear that efforts should be taken to fully grasp the 
complex relationship between dietary behaviors and blood pressure. To date, sub-optimal 
diet quality has been highlighted as the leading risk factor for disability and death in the 
U.S. and in 2010, 678,000 deaths were linked to poor diet quality including insufficient 
fruit, vegetable, and whole grain intake as well as excess consumption of sodium.1 Given 
these statistics, numerous researchers have focused their attention on identifying food items 
that may be beneficial for reducing elevated blood pressure121 while other researchers have 
directed their attention on foods that may be adversely associated with blood pressure. In 
such studies, several themes have emerged including the relationship between potassium 
and blood pressure, sodium and blood pressure, caffeine and blood pressure, and vitamin C 
and blood pressure.  
The Effect of Potassium on Blood Pressure 
In humans, potassium is the most abundant cation. It is primarly contained in the 
cells but a small percentage can be found in extracellular fluid.122 In healthy individuals, 
approximately 90% of potassium is absorbed and then excreted by the kidneys. However, 
multiple factors, such as the activation of potassium channels, influence the secretion of 
potassium.122,123 Once potassium channels are activated, endothelial cells and vascular tone 
may be regulated. Findings from animal studies have demonstrated that supplementation of 
potassium is effective for improving endothelial function by increasing the production of 
nitric oxide.124 Additionally, supplementation of potassium may cause a stimulation of 
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potassium channels resulting in vasodilation of arteries.125 In human subjects, a meta-
analysis of more than thirty randomized controlled studies have also reported the 
importance of potassium consumption for blood pressure regulation. More specifically, low 
potassium intake may lead to increased levels of blood pressure while increased levels of 
potassium may prevent or treat  sub-optimal blood pressure levels.121,126 
The Effect of Sodium on Blood Pressure 
A mineral of considerable interest in blood pressure regulation is sodium. In the 
U.S. alone, approximately 58,000 annual deaths are linked to excess sodium consumption 
(greater than 2.0 grams per day). This accounts for 1 in 16 overall deaths from 
cardiovsacular disease and 1 in 8 deaths from cardiovascular disease in individuals 70 years 
old or younger. Globally, nearly 1 in 10 individuals or 1.65 million annual deaths were 
attributable to excess sodium consumption.1 While there is no denying that excess sodium 
is deleterious to health, adequate amounts of this mineral are important to maintain 
homeostasis. Specifically, sodium plays an essential role in maintaining pH balance, 
regulating extracellular fluid, and is a key cation involved in controlling cellular function 
across multiple organ systems. Additionally, sodium is important to ensure arterial pressure 
and adequate blood volume.127,128 Under normal physiological conditions, decreasing 
sodium intake is crucial for decreasing blood volume, inducing the release of renin, and 
subsequently producing angiotensin II. Taken together, renin and angiotensin II hormones 
result in a vasoactive response thereby constricting blood vessels, when necessary.126  
Findings from a longitudinal population study conducted on almost 1500 
participants with high blood pressure over a six-year period showed that, on average, there 
were significant annual increases in blood pressure.129 Specifically, systolic blood pressure 
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increased by approximately 0.37 mm Hg while diastolic blood pressure increased by 
roughly 0.47 mm Hg. In spite of increases in overall blood pressure, there were no 
significant changes in 24-hour urinary excretion of sodium over the course of the trial. 
Next, a randomized, controlled cross-sectional study conducted to assess the effects of 
sodium restriction on blood pressure in subjects with resistant hypertension indicated that 
excessive dietary sodium contributed to resistance to anti-hypertensive medication.129 Next, 
a landmark multi-center cross-sectional study conducted to examine the effects of sodium 
consumption on blood pressure indicated that there was a positive association between high 
levels of sodium intake and blood pressure. Specifically, increased dietary sodium led to 
significantly higher systolic and diastolic blood pressures.130 
The Effect of Caffeine on Blood Pressure 
 In addition to potassium and sodium, another agent that has been linked to blood 
pressure regulation is caffeine. While the majority of previous studies which have assessed 
the effects of caffeine consumption on blood pressure have been primarly conducted on 
healthy populations, it is important to note that there are several landmark investigations 
conducted on hypertensive populations.131,132 For example, a randomized crossover trial 
showed that consumption of caffeine resulted in significant increases in both systolic and 
diastolic blood pressures in post-menopausal women undergoing hormone replacement 
therapy.133  
Next, a systematic review conducted on hypertensive subjects indicated that 
increased caffeine consumption of 200-300 mg resulted in a mean increase of systolic 
blood pressure by 8.1 mm Hg and by 5.7 mm Hg for diastolic blood pressure. Further, 
increases in blood pressure were observed during the first hour of intake, and remained 
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elevated for ≥3 hours. However, there were no significant differences in blood pressure 
seen in studies assessing the longer-term effects (approximately two weeks) of coffee, 
decaffeinated coffee, and caffeine-free beverage consumption.134  
The Effect of Vitamin C on Blood Pressure 
 Ascorbic acid, more commonly known as vitamin C, is a micronutrient abundant 
in many fruits, vegetables, dietary supplements, fortified ready-to-eat cereals, and select 
beverages.135 To date, researchers agree that vitamin C is effective for reducing oxidative 
stress and for enhancing endothelial function via the production of nitric oxide. In fact, as 
early as the mid-1940s, vitamin C supplementation was thought to result in anti-
hypertensive effects in human trials.135,136 Further, it has also been suggested that 
increased levels of vitamin C may reduce blood pressure.137 
 A systematic review of randomized controlled trials conducted to determine the 
relationship between vitamin C supplementation and blood pressure found significant 
reductions in both systolic and diastolic pressures. An 8-week randomized, double-blind, 
placebo controlled crossover trial indicated that hypertensive subjects had a reduction of 
systolic blood pressure by approximately 24.85 mm Hg and a reduction of diastolic blood 
pressure by approximately 24.85 mm Hg following vitamin C supplementation.135,138 
Next, long-term supplementation (for a duration of approximately three months) of 
vitamin C appeared to affect blood pressure somewhat similarly. Specifically, a double-
blind, randomized placebo-controlled crossover trial conducted on older men and women 
(aged 60 and above) showed a modest, but significant decrease in ambulatory systolic 
blood pressure.139 Similarly, in subjects with essential hypertension, vitamin C 
supplementation appeared to be an effective method for improving impaired endothelial    
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by reversing the effects of free radicals which are associated with endothelial 
dysfunction.79 
Summary 
 Overall, a significant amount of research has been conducted to better understand 
the complex relationship between food and the prevention of hypertension and 
hypertension-related ailments in various study populations. Despite this forward progress, 
many aspects of this chronic condition remain unknown especially as it relates to the 
consumption of nitrate-rich dietary sources. Further, the overall prevalence of 
hypertension continues to increase, a trend that is primarily driven by post-menopausal 
women.140 Thus, given the apparent gaps in the current body of literature pertaining to the 
effects of nitrate-rich dietary sources and cardiovascular health in post-menopausal 
women, our randomized, placebo-controlled, crossover trial sought to compare the effects 
of a fresh nitrate-rich vegetable salad to a canned low-nitrate vegetable medley, 
consumed twice per day, on plasma nitrate/nitrite concentration, peripheral and central-
aortic systolic and diastolic blood pressures, pulse wave velocity, and flow-mediated 
dilation in healthy, post-menopausal women residing in Phoenix, Arizona. 
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CHAPTER 3 
METHODS 
 
Study Design 
A randomized, placebo-controlled, crossover trial was conducted at Arizona State 
University (ASU) from June 2016 to August 2016. This feeding trial compared the 
effects of fresh nitrate-rich vegetable salads versus canned low-nitrate canned vegetables 
on plasma nitrate/nitrite concentration, peripheral and central-aortic systolic and diastolic 
blood pressures, pulse wave velocity, and flow-mediated dilation in healthy, post-
menopausal women residing in Phoenix, Arizona. Approval for this project was granted 
by the Institutional Review Board (IRB) at Arizona State University on May 23, 2016 
(Appendix A).  
Participants 
Subject Selection  
Healthy, post-menopausal women were recruited from Arizona State University 
(ASU) campuses and surrounding cities in the Phoenix Metropolitan area. Written 
informed consent was obtained from all subjects prior to enrollment into the trial 
(Appendix B).  
Inclusion and Exclusion Criteria 
Inclusion criteria for this trial were healthy, post-menopausal women regardless 
of race/ethnicity, weight status, BMI classification, and socioeconomic status with blood 
pressure levels (≥ 115/70 mm Hg and < 140/80 mm Hg), subjects not taking hypertensive 
medication, non-smokers, subjects not consuming alcoholic beverages, multi-vitamins, 
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antihistamines, decongestants, and those not using antiseptic/antibacterial mouthwash for 
the duration of the trial. Subjects who failed to meet these parameters were excluded 
from the trial. 
Recruitment Strategies  
Subjects were recruited from the ASU Phoenix, West, Tempe, and Polytechnic 
campuses via online and in-person flyers in June and July of 2016. Recruitment efforts 
were extended to public settings including libraries within surrounding cities as well as 
various online platforms. Flyers informed potential subjects that the 8-week trial was 
designed to examine whether blood vessel function and blood pressure would improve 
following the consumption of a vegetable salad versus a vegetable medley consumed 
twice per day during the treatment phases (Appendix C). An invitation to complete an 
online pre-screening questionnaire was extended to interested subjects (Appendix D), and 
qualifying individuals were invited to meet with study personnel at the ASU Downtown 
Phoenix campus to further discuss the trial.  
Study Protocols 
 A randomized, placebo-controlled, crossover trial was employed to assess study 
outcomes (Appendix E). Pre-screening occurred via an online questionnaire and prior to 
the beginning of the trial subjects visited the Arizona Biomedical Collaborative (ABC) 
building in Phoenix. During this visit (visit one), further screening (e.g., Health History 
Questionnaire (HHQ) (Appendix F), Food Frequency Questionnaire (FFQ) (Appendix G) 
and blood pressure) was completed, and eligible subjects were asked to refrain from 
antiseptic/antibacterial mouthwash for the duration of the study. Additionally, subjects 
were asked to refrain from multi-vitamins, antihistamines, and decongestants three days 
38 
prior to study visits two through five and from alcoholic beverages, caffeine, and heavy 
exercise 12-hours prior to study visits two through five. Next, instructions were given to 
subjects to maintain their usual diet and exercise routine, and to restrict medium- and 
high-nitrate fruits and vegetables (list provided) for the duration of the study. Further, 
subjects were randomized to either the intervention (high-nitrate: ~445 mg nitrates per 
day) or the placebo (low-nitrate: <50 mg nitrates per day) group, and a study protocol 
checklist was maintained by the investigators (Appendix H). The vegetable medley 
consisted of canned, low-nitrate vegetables with little- or no-added salt. Given the 
crossover design of the trial, the following protocols were followed for all subjects during 
visits two through five.  
At visit 2, baseline measurement of blood pressure, pulse wave analysis, pulse 
wave velocity, flow-mediated dilation, and plasma nitrates were obtained. At visit 3, 
scheduled at the end of the 10-day feeding period, measurements obtained at visit 2 were 
repeated. Following the washout period (two to three weeks in duration), visit 4 was 
scheduled. At visit 4, peripheral blood pressure, central aortic blood pressure, pulse wave 
velocity, flow-mediated dilation, and plasma nitrate/nitrite measurements were obtained, 
and subjects were given either a 10-day supply of the high-nitrate vegetable salad or a 10-
day supply of the vegetable medley. Finally, visit 5 occurred following the second 10-day 
feeding period, and peripheral blood pressure, central aortic blood pressure, pulse wave 
velocity, flow-mediated dilation, and plasma nitrate/nitrite measurements were once 
again obtained. In totality, measurements of central aortic blood pressure, pulse wave 
velocity, flow-mediated dilation, and plasma nitrates/nitrites were obtained at four time 
points: prior to the first trial phase, and following each trial phase. Conversely, peripheral 
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blood pressure and weight were collected at five time points: during the screening visit, 
and prior to and after each of the two feeding periods.  
Outcome Measures 
Plasma Nitrate/Nitrate Concentration 
 Subjects provided a fasting blood sample at each of the four time points. Samples 
were collected into EDTA vacutainers, and plasma was separated by centrifugation. 
Plasma samples were then filtered using 30 kDa MWCO micro-centrifuge filters to 
remove hemoglobin and large plasma proteins. Nitrate/nitrite concentration in plasma 
samples were then measured using a commercially available kit (Cat. No. 780001, 
Cayman Company, Ann Arbor, MI) according to the instructions. 
Peripheral Blood Pressure 
Upon entering the study laboratory, subjects were asked to lie down in a dimly lit 
room where their resting peripheral blood pressure (systolic and diastolic) was measured 
at zero and ten minutes to ensure hemodynamic stability using an Omron® Auto Cuff 
Blood Pressure Monitor. The Omron® one-touch blood pressure monitor was equipped 
with IntelliSense technology developed by Omron Healthcare to inflate and deflate at the 
optimum level depending on the individual user’s arm size. Next, a non-invasive 
SphygmoCor XCEL (AtCor Medical, Sydney, NSW, Australia) system was employed to 
measure peripheral blood pressure. Subjects’ peripheral blood pressure was obtained a 
total of three times and the average of the last two measurements was recorded to 
determine the final peripheral blood pressure. 
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Central-aortic Blood Pressure 
Following peripheral blood pressure measurements, a non-invasive SphygmoCor 
XCEL (AtCor Medical, Sydney, NSW, Australia) system was used to measure pulse 
wave analysis to derive a central aortic systolic and diastolic blood pressure reading. A 
blood pressure cuff attached to the SphygmoCor XCEL system was placed around 
subjects’ non-dominant upper arm above the elbow. The SphygmoCor XCEL device first 
obtained subjects’ resting heart rate and resting blood pressure; next the system captured 
subjects’ brachial waveform. By utilizing the brachial generalized transfer function of the 
device, data on the (1) central-aortic waveform, (2) central-aortic systolic pressure, (3) 
central-aortic pulse pressure, and (4) an augmentation index were obtained. Subjects’ 
pulse wave analysis was obtained a total of three times and the average of the last two 
measurements was recorded to determine the final central-aortic blood pressure. 
Pulse Wave Velocity 
Following pulse wave analysis measurements, the non-invasive SphygmoCor 
XCEL (AtCor Medical, Sydney, NSW, Australia) system was employed to determine 
carotid-femoral pulse wave velocity, a measure of arterial stiffness. During this 
procedure, a blood pressure cuff was placed around each subject’s upper thigh and 
carotid and femoral pulse rate was identified. Next, distances from the femoral pulse to 
the topmost point above of the blood pressure cuff; from the sternal notch to the topmost 
point above the blood pressure cuff; and from the carotid pulse to the sternal notch were 
measured and entered into the SphygmoCor XCEL software. Afterward, a pen-like 
tonometer was placed directly above the carotid pulse in the neck, and firm and stable 
pressure was applied until the SphygmoCor XCEL device computed carotid-femoral 
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arterial stiffness. To assess arterial stiffness, the SphygmoCor XCEL device determines 
the time it takes for the pulse to travel from the carotid artery in the neck to the femoral 
artery in the thigh. Subjects’ pulse wave velocity measurements were obtained a total of 
three times and the average of the last two measurements was recorded to determine 
carotid-femoral arterial stiffness. 
Flow-mediated Dilation 
Flow-mediated dilation of the brachial artery was obtained via a resolution 2D and 
Doppler ultrasound (Terason uSmart3300 ultrasound, Terason Ultrasound, Burlington, 
MA) with a linear-array transducer at a transmit frequency of 15 MHz. Following a 
fifteen-minute resting period, images of each subject’s brachial artery were captured 
while lying on their back in a comfortable position with the non-dominant arm extended 
and immobilized. Images were captured from a longitudinal plane near the antecubital 
fold, and were analyzed and recorded. 
Statistical Analyses 
SPSS (Statistical Package for the Social Sciences) v. 23 was utilized for all 
statistical analyses. Findings were considered significant at a p-value < 0.05.  Results 
were expressed as mean ± standard deviation. Due to the small sample size (n=5), the 
researchers were unable to determine if the normality assumption was met. Thus, non-
parametric Wilcoxon Signed-Rank tests were utilized to compare mean differences 
between conditions. Additionally, effect sizes were included for all outcome measures.  
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CHAPTER 4 
RESULTS 
Subject Characteristics and Demographics 
Of the interested subjects (n=25), (n=17) subjects met the inclusion criteria and 
were invited to meet with study personnel for the initial screening visit. Of the eligible 
subjects (n=9), a total of five subjects completed the pilot study and communicated that 
they consumed the vegetable salad or canned vegetable medley during the assigned 
feeding phases of the trial. Consumption of vegetable salads and canned vegetable 
medley was confirmed by compliance calendars. Descriptive statistics, as illustrated in 
Table 1, indicate that the mean age of subjects at screening was 52.6 ± 5.7 years. As 
expected, there were no changes in age during the trial. The mean weight at screening 
was 68.5 ± 17.7 kg, and there were no significant fluctuations in weight following the 
high- or low-nitrate phases of the study (p=0.757 and p=0.959, respectively).  
Table 1. Subject characteristics and demographics 
 
 Minimum Maximum Mean 
    
Age (years) 44.0 60.0 52.6 ± 5.7 
Height (cm) 160.0 168.0 163.4 ± 2.9 
Weight (kg) 52.1 94.9 68.5 ± 17.7 
Body fat (%) 20.9 48.5 33.7 ± 11.2 
PA score 15.0 102.0 60.8 ± 33.5 
These data were based on n=5 subjects. Descriptive statistics were performed using SPSS Statistical Analysis system 
23.0. Data are expressed as mean ± standard deviation. Data are considered statistically significant at p-value < 0.05, 
and p-values were provided for change in weight following the low and high nitrate phases of the trial.  
 
Plasma Nitrate/Nitrite Concentration 
It was hypothesized that subjects would have a higher plasma nitrate/nitrite 
concentration after consuming a fresh high-nitrate vegetable salad twice per day than 
43 
after consuming a canned vegetable medley twice per day. As outlined in table 2, subjects 
had a higher plasma nitrate/nitrite concentration after consuming a fresh high-nitrate 
vegetable salad twice per day (pre-intervention = 40.8 ± 15.3 µM/L; post-intervention = 
100.0 ± 40.6 µM/L) than after consuming a canned vegetable medley twice per day (pre-
control = 51.9 ± 18.8 µM/L; post-control = 46.7 ± 17.8 µM/L). When comparing the 
effects of the high-nitrate and the low-nitrate conditions, there was a statistically 
significant increase in plasma nitrate/nitrite concentration (p = 0.043) following twice 
daily consumption of the fresh, nitrate-rich vegetable salad. Given these preliminary 
findings, the hypothesis was supported.  
Table 2. A comparison of plasma nitrate/nitrite concentration between the high and low 
nitrate phases of the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Plasma Nitrate/Nitrite (µM/L)     
Pre 40.8 ± 15.3 51.9 ± 18.8   
Post 100.0 ± 40.6 46.7 ± 17.8   
Δ 59.5 ± 33.4 -5.2 ± 18.0 0.043* 0.640 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05. 
 
Peripheral Systolic Blood Pressure 
It was hypothesized that subjects would have lower peripheral systolic blood 
pressure after consuming a fresh high-nitrate vegetable salad twice per day than after 
consuming a canned vegetable medley twice per day. As outlined in table 3, subjects had 
lower peripheral systolic blood pressure after consuming a fresh high-nitrate vegetable 
salad twice per day (pre-intervention = 118.7 ± 9.2 mm Hg; post-intervention = 116.6 ± 
9.8 mm Hg) than after consuming a canned vegetable medley twice per day (pre-control 
= 123.3 ± 6.8 mm Hg; post-control = 127.7 ± 11.6 mm Hg). When comparing the change 
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in peripheral systolic blood pressure in the high-nitrate and the low-nitrate conditions, 
there were no statistically significant differences in peripheral systolic blood pressure (p 
= 0.345). Given these preliminary findings, the hypothesis was not supported.  
Table 3. A comparison of peripheral systolic blood pressure between the high and low 
nitrate phases of the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Peripheral SBP (mm Hg)     
Pre 118.7 ± 9.2 123.3 ± 6.8   
Post 116.6 ± 9.8 127.7 ± 11.6   
Δ -2.1 ± 6.2 4.4 ± 8.0 0.345 0.299 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05. 
 
Peripheral Diastolic Blood Pressure 
It was hypothesized that subjects would have lower peripheral diastolic blood 
pressure after consuming a fresh high-nitrate vegetable salad twice per day than after 
consuming a canned vegetable medley twice per day. As outlined in table 4, subjects had 
lower peripheral diastolic blood pressure after consuming a fresh high-nitrate vegetable 
salad twice per day (pre-intervention = 72.8 ± 5.3 mm Hg; post-intervention = 71.7 ± 5.4 
mm Hg) than after consuming a canned vegetable medley twice per day (pre-control = 
76.6 ± 4.0 mm Hg; post-control = 77.5 ± 6.2 mm Hg). When comparing the effects of the 
high-nitrate and the low-nitrate conditions, there were no statistically significant 
differences in peripheral diastolic blood pressure (p = 0.684). Given these preliminary 
findings, the hypothesis was not supported.  
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Table 4. A comparison of peripheral diastolic blood pressure between the high and low 
nitrate phases of the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Peripheral DBP (mm Hg)     
Pre 72.8 ± 5.3 76.6 ± 4.0   
Post 71.7 ± 5.4 77.5 ± 6.2   
Δ -1.1 ± 4.8 0.9 ± 5.3 0.684 0.128 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05. 
 
Central-aortic Systolic Blood Pressure 
It was hypothesized that subjects would have lower central-aortic systolic blood 
pressure after consuming a fresh high-nitrate vegetable salad twice per day than after 
consuming a canned vegetable medley twice per day. As outlined in table 5, subjects had 
lower central-aortic systolic blood pressure after consuming a fresh high-nitrate vegetable 
salad twice per day (pre-intervention = 111.8 ± 8.8 mm Hg; post-intervention = 109.9 ± 
8.7 mm Hg) than after consuming a canned vegetable medley twice per day (pre-control 
= 115.9 ± 5.8 mm Hg; post-control = 119.7 ± 11.6 mm Hg). When comparing the effects 
of the high-nitrate and the low-nitrate conditions, there were no statistically significant 
differences in central-aortic systolic blood pressure (p = 0.225). Given these preliminary 
findings, the hypothesis was not supported.  
Table 5. A comparison of central-aortic systolic blood pressure between the high and low 
nitrate phases of the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Central SBP (mm Hg)     
Pre 111.8 ± 8.8 115.9 ± 5.8   
Post 109.9 ± 8.7 119.7 ± 11.6    
Δ -1.9 ± 4.5 3.8 ± 8.1 0.225 0.384 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05. 
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Central-aortic Diastolic Blood Pressure 
It was hypothesized that subjects would have lower central-aortic diastolic blood 
pressure after consuming a fresh high-nitrate vegetable salad twice per day than after 
consuming a canned vegetable medley twice per day. As outlined in table 6, subjects had 
lower central-aortic diastolic blood pressure after consuming a fresh high-nitrate 
vegetable salad twice per day (pre-intervention = 73.8 ± 5.7 mm Hg; post-intervention = 
72.4 ± 5.4 mm Hg) than after consuming a canned vegetable medley twice per day (pre-
control = 77.4 ± 4.5 mm Hg; post-control = 78.3 ± 6.4 mm Hg). When comparing the 
effects of the high-nitrate and the low-nitrate conditions, there were no statistically 
significant differences in central-aortic diastolic blood pressure (p = 0.465). Given these 
preliminary findings, the hypothesis was not supported.  
Table 6. A comparison of central-aortic diastolic blood pressure between the high and 
low nitrate phases of the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Central DBP (mm Hg)     
Pre 73.8 ± 5.7 77.4 ± 4.5   
Post 72.4 ± 5.4  78.3 ± 6.4   
Δ -1.4 ± 4.5 0.9 ± 4.8 0.465 0.231 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05. 
 
Pulse Wave Velocity 
It was hypothesized that subjects would have lower (improved) pulse wave 
velocity after consuming a fresh high-nitrate vegetable salad twice per day than after 
consuming a canned vegetable medley twice per day. As outlined in table 7, pulse wave 
velocity was not significantly different (p = 0.465) in subjects after consuming a fresh 
high-nitrate vegetable salad twice per day (pre-intervention = 7.5 ± 0.9 min/sec; post-
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intervention = 7.6 ± 0.1 min/sec) than after consuming a canned vegetable medley twice 
per day (pre-control = 8.1 ± 1.6 min/sec; post-control = 7.7 ± 1.0 min/sec). Given these 
preliminary findings, the hypothesis was not supported.  
Table 7. A comparison of pulse wave velocity between the high and low nitrate phases of 
the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Pulse wave velocity (min/sec)     
Pre 7.5 ± 0.9 8.1 ± 1.6   
Post 7.6 ± 1.0 7.7 ± 1.0   
Δ 0.1 ± 0.6 -0.4 ± 1.7 0.465 0.231 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05. 
 
Flow-mediated Dilation 
It was hypothesized that subjects would have higher (improved) flow-mediated 
dilation after consuming a fresh high-nitrate vegetable salad twice per day than after 
consuming a canned vegetable medley twice per day. As outlined in table 8, subjects had 
higher (improved) flow-mediated dilation after consuming a fresh high-nitrate vegetable 
salad twice per day (pre-intervention = 6.9 ± 2.9 %; post-intervention = 8.8 ± 3.6 %) than 
after consuming a canned vegetable medley twice per day (pre-control = 6.9 ± 4.2 %; 
post-control = 5.2 ± 2.9 %). When comparing the effects of the high-nitrate and the low-
nitrate conditions, the difference in flow-mediated dilation tended to approach statistical 
significance (p = 0.080). Given these preliminary findings, the hypothesis was not 
supported.  
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Table 8. A comparison of flow-mediated dilation between the high and low nitrate 
phases of the study 
 
 High Nitrate Low Nitrate P-value Effect Size 
Flow-mediated dilation (%)     
Pre 6.9 ± 2.9 6.9 ± 4.2   
Post 8.8 ± 3.6 5.2 ± 2.9   
Δ 1.9 ± 5.0 -1.7 ± 1.8 0.080 0.554 
These data were based on n=5 subjects. Statistics were performed using SPSS Statistical Analysis system 23.0. All 
values represent mean ± Standard Deviation (SD). Data are considered statistically significant at p-value < 0.05.  
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CHAPTER 5 
DISCUSSION 
This 8-week randomized, placebo-controlled, crossover trial sought to compare 
the effects of a fresh, high-nitrate vegetable salad versus a canned, low-nitrate vegetable 
medley on plasma nitrate/nitrite concentration, peripheral blood pressure, central-aortic 
blood pressure, pulse wave velocity, and flow-mediated dilation in healthy post-
menopausal women. Non-parametric Wilcoxon Signed-Rank tests compared mean 
differences between conditions. In alignment with the crossover design protocol, all 
subjects underwent both the intervention and the control conditions of the trial and 
adhered to a two to three week washout period between feeding phases. Following an 
extensive literature review, several research hypotheses were developed for this trial.  
Plasma Nitrate/Nitrite Concentration.  As hypothesized, there was a statistically 
significant increase in plasma nitrate/nitrite concentration following the high-nitrate 
intervention versus the low-nitrate condition. These findings are in alignment with 
previous research in which subjects ingested a high-nitrate intervention. For instance, a 
randomized crossover study, which sought to assess the short-term effects of green leafy 
vegetables on blood pressure and arterial stiffness in a sample of subjects with high-normal 
blood pressure observed a statistically significant increase in salivary and plasma nitrate 
and nitrite concentration.71 In a similar study, daily consumption of 250 ml of beetroot juice 
over a two-week period resulted in significant increases in plasma nitrate/nitrite 
concentration.11  
Peripheral and Central-aortic Blood Pressures.  Following the 8-week trial, there were 
no statistically significant differences in peripheral and central-aortic systolic or diastolic 
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blood pressures between the treatment and control conditions. These findings suggest that 
consumption of a high-nitrate vegetable salad (≥ 250 mg/100 g fresh weight) did not offer 
significant antihypertensive benefits. Findings from this study do not align with previous 
research. A systematic review and meta-analysis of the effects of inorganic nitrate and 
beetroot juice supplementation revealed that nitrate supplementation was effective for 
reducing blood pressure in adult populations.9 Similarly, a crossover trial assessing the 
intake of supplementary beetroot juice administered to healthy young subjects 
demonstrated a significant reduction of approximately 4% in both systolic and diastolic 
blood pressure which was maintained for roughly two weeks with continued administration 
of the intervention.95 In other studies, consumption of high-nitrate food or beverage items 
resulted in an increased bioactivation of nitric oxide which led to vasoprotective outcomes 
in as little as three hours after ingestion.95,97 However, to the best of the investigators’ 
knowledge, no trials have assessed the effectiveness of fresh, high-nitrate vegetable salads 
on blood pressure in post-menopausal women. Further, it is important to note that the 
present study was underpowered as a result of the small sample of study participants.  
Pulse Wave Velocity.  Contrary to the researcher’s hypothesis, there were no statistically 
significant improvements in pulse wave velocity following the high-nitrate intervention 
versus the low-nitrate control condition. It is important to note that previous research has 
found that post-menopausal women generally have higher pulse wave velocity levels than 
menstruating women.75 To date, no known studies have exclusively assessed the 
effectiveness of dietary nitrates on pulse wave velocity in post-menopausal women. The 
few studies which have examined the effectiveness of dietary nitrates on pulse wave 
velocity have included men and women with regular menses.15,141,142  In particular, a 
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randomized, double-blind crossover trial conducted on healthy adults revealed that 
supplementation of inorganic nitrate resulted in a significant decrease (improvement) in 
pulse wave velocity.15,141 Conversely, another randomized-controlled crossover trial in 
which high-nitrate spinach was supplemented did not show any significant reductions 
(improvements) in pulse wave velocity measurements.142  
Flow-mediated Dilation.  The investigators hypothesized that flow-mediation would 
increase (improve) following the high-nitrate intervention versus the low-nitrate control 
condition. Findings suggest partial support for this hypothesis with an effect size that 
indicates that the trial was just underpowered to see an effect of the high-nitrate 
intervention. To date, no known studies have exclusively assessed the effectiveness of 
dietary nitrates on flow-mediated dilation in post-menopausal women. The few studies 
which have examined the effectiveness of dietary nitrates on flow-mediated dilation have 
shown mixed results. In particular, a study conducted on healthy adults revealed that 
supplementation of inorganic nitrate did not result in a significant increase (improvement) 
in flow-mediated dilation.141 Conversely, a randomized-controlled crossover trial 
examining the effects of flavonoid-rich apples and high-nitrate spinach in healthy adult 
men and women resulted in a significant increase (improvement) in flow-mediated 
dilation.15,141 
Strengths.  This randomized, placebo-controlled trial had several notable strengths. First, 
findings indicate that the high-nitrate intervention had a sustained effect on plasma 
nitrate/nitrite concentration given that there was a statistically significant improvement in 
plasma nitrate/nitrite concentration even after a 12-hour overnight fast. Next, the study’s 
crossover design allowed the researchers to assess within-subject changes following the 
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control and intervention phases of the trial. By utilizing a crossover design as well as 
instructing subjects to observe a pre-determined washout phase, the researchers attained a 
comparable level of statistical power as with a parallel arm trial – this was especially 
appropriate given the small sample size of this trial. Based on fidelity calendars, there 
was a 98% overall compliance for consumption of the high-nitrate salads and a 90% 
overall compliance for consumption of the low-nitrate canned vegetables. Other strengths 
are that subjects were asked to refrain from multivitamins, antihistamines, and 
decongestants three days prior to study visits two through five, and from alcoholic 
beverages, caffeine, and heavy exercise 12-hours prior to study visits two through five. 
Additionally, subjects on antihypertensive medications and those taking 
antiseptic/antibacterial mouth rinses were excluded from the trial. Researchers concur 
that consumption of caffeine and antiseptic/antibacterial mouth rinses may interfere with 
blood pressure readings.105, 131 
Limitations.  As with all research, there were inherent limitations to this trial. Despite the 
goal of enrolling 15 subjects, only 5 subjects completed the trial. Given the limited 
sample size, this trial may have lacked the power to detect statistically significant effects. 
Yet another limitation of this trial was that the actual nitrate levels present in the 
vegetable salads were unknown. Future research seeking to assess the effectiveness of a 
high-nitrate vegetable salad on cardiovascular parameters in post-menopausal subjects 
may benefit from obtaining vegetables from a single grower or collecting and testing 
nitrate levels in soil samples in which vegetables were obtained, analyzing the nitrate 
content in vegetables once procured, weighing ingredients, preparing salads for subjects, 
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ensuring that salads are consumed in the presence of the investigators, and recruiting a 
larger sample of subjects.  
Conclusion.  This 8-week randomized, placebo-controlled, crossover trial suggests that 
twice daily consumption of a high-nitrate vegetable salad (≥ 250 mg/100 g fresh weight) 
does not significantly decrease peripheral systolic or diastolic blood pressure, central-
aortic systolic or diastolic blood pressure or improve flow-mediated dilation or pulse 
wave velocity when compared to the low-nitrate condition. Conversely, when compared 
to the low-nitrate condition, twice daily consumption of a high nitrate vegetable salad did 
significantly increase plasma nitrate/nitrite concentration.  
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APPROVAL: MODIFICATION 
Carol Johnston 
SNHP: Nutrition 
602/827-2265 
CAROL.JOHNSTON@asu.edu 
 
Dear Carol Johnston: 
On 6/22/2016 the ASU IRB reviewed the following protocol: 
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Title: A Comparison of a High-Nitrate versus a Low-Nitrate 
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ARE YOU INTERESTED IN NATURAL 
STRATEGIES THAT TARGET   
BLOOD PRESSURE? 
ASU is starting a research study to examine the 
effects of two types of vegetables on blood 
pressure. 
  
THE NUTRITION PROGRAM AT ASU IS RECRUITING HEALTHY,  
POST-MENOPAUSAL WOMEN (40-70 YEARS OLD) TO EXAMINE THE 
EFFECTS OF TWO TYPES OF VEGETABLES ON BLOOD PRESSURE. 
  
Participation will include: 
 Traveling to the ASU Downtown Phoenix campus on 5 occasions over an 8-week 
period (visit 1 will last about 30 minutes, and visits 2-5 will last about 1 hour 
each.)   
 Consuming a vegetable salad or a vegetable medley (canned vegetables), twice 
per day, during each of the two 10-day intervention phases of the study. The 
vegetables include celery, spinach, lettuces, green beans, sweet peas, and corn. 
 Obtaining blood pressure, blood samples, and cardiovascular function 
measurements.   
  
You will receive $30 in Target gift cards. 
 
INTERESTED? Please visit our recruitment site:   
 
https://www.surveymonkey.com/r/VeggiesToLowerBP 
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A Comparison of a High-Nitrate versus a Low-Nitrate Diet on Cardiovascular 
Health in Post-Menopausal Women  
Thank you for choosing to participate in this survey! 
ASU Nutrition Professors Karen Sweazea and Carol Johnston and their graduate student, 
Selicia Mayra, are inviting you to participate in this screening process, which will consist 
of questions specific to your health, demographics, and scheduling availability. You have 
the right to skip any question(s) you are uncomfortable answering, or to stop this survey 
at any time.  
Your participation in this survey and the research study is completely voluntary, and you 
may choose to withdraw from the study at any time without consequence. Your responses 
to this survey, and participation in this research study will be strictly confidential.  
If you meet the inclusion criteria for the study, you will be contacted to schedule an in-
person appointment at Arizona State University (Downtown Phoenix campus). This 
initial appointment should last approximately 30 minutes.  
For questions concerning this research study, please contact the research team at 
smayra@asu.edu or (480) 326-4591. Should you have questions about your rights as a 
participant in this research study, or if you feel you have been placed at risk, please 
contact the Chair of the Human Subjects Institutional Review Board, through the ASU 
Office of Research Integrity and Assurance at (480) 965-6788.  
By completing the survey below, you are agreeing to be screened for the (Nitrate-
enriched Diet to Promote Cardiovascular Health) study, and to be contacted by 
investigators (via e-mail) to schedule an in-person appointment, should you qualify for 
the study.  
1. Please provide your e-mail address. 
2. How old are you (in years)? 
3. What is your gender (male or female)? 
4. Do you currently have a menstrual period? 
5. Have you been told by your doctor that you have hypertension (high blood pressure)? 
6. Are you currently on medication for high blood pressure?  
7. If you currently use an alcohol-based mouthwash, would you be willing to refrain 
from further use for the duration of the study? 
8. If you currently take aspirin and/or anti-inflammatory medications, would you be 
willing to refrain from further use for three days prior to blood draws? 
9. If you currently take a multivitamin/mineral supplement, would you be willing to 
refrain from further use for three days prior to blood draws? 
10. If you currently drink alcohol and/or caffeine (e.g., coffee), would you be willing to 
refrain from further use for 12 hours prior to blood draws? 
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11. If you currently smoke, would you be willing to refrain from smoking for 12 hours 
prior to blood draws? 
12. If you currently exercise, would you be willing to refrain from heavy exercise for 12 
hours prior to blood draws? 
13. Would you be willing to refrain from all food and beverages, NOT including water, 
for 12 hours prior to blood draws? 
14. Are you willing to eat a vegetable salad or a vegetable medley (canned vegetables) 
twice per day, and also record your food and beverage intake for a 10-day period? 
15. Do you have any known food allergies or other food restrictions? If yes, please list 
_______. 
16. Do you currently follow a special diet (e.g., low-fat, DASH, weight loss/weight 
gain)? If yes, please list _______.  
17. In a typical week, how many servings of fruits and vegetables do you eat? 
18. Please list examples of fruits and vegetables you eat on a daily or weekly basis.  
19. Would you be willing and able to attend 5 in-person visits at the ASU Downtown 
Phoenix campus? Visit one should last 30 minutes, and visits 2-5 should last 1 hour 
each. 
20. Are you willing to provide fasting blood samples from an arm vein at 4 of the study 
visits? 
Thank you for taking the time to participate in this survey. 
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Health History Questionnaire              ID#________________ 
Age:________                    Height:_______ cm. 
Gender (please circle):  Female    Male     Weight:_______ kg. 
Smoked cigarettes in the past year?       
(please circle):  Yes No 
1. Are you currently taking any blood pressure medication?      Y     N 
 If yes, what medications and how often? 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
2. Has a doctor ever told you that you have high blood pressure?      Y     N 
3. Do you currently take supplements? (Multivitamins, minerals, herbs, etc.)    Y     N 
If yes, what supplements and how often? 
________________________________________________________________________ 
 ________________________________________________________________________ 
4. Do you have any known food allergies?                                                        Y     N   
If yes, what foods? 
________________________________________________________________________ 
 ________________________________________________________________________ 
5. Are you willing to participate in an 8-week long study, and consume a vegetable salad or a   
    vegetable medley (canned vegetables) twice daily for the intervention phase of the  
     study?                         Y     N                                                                                                             
6. Are you willing to provide blood samples from an arm vein on 4 occasions during the  
    study?              Y     N 
7. Are you willing to have your blood pressure taken on 5 occasions during the study?   Y     N 
8. Are you willing to have your blood vessel function assessed on 4 occasions during the  
    study?                 Y     N 
9. Are you willing to travel to the ASU Downtown Phoenix campus on 5 separate  
    occasions?             Y     N 
10. Would you be able and willing to refrain from antibacterial mouthwash for the duration of the   
      8-week study?                      Y     N 
11. Would you be able and willing to refrain from aspirin, vitamins/minerals, and anti- 
      inflammatory medication for three days prior to blood draws?      Y     N 
To be 
completed 
by 
investigator 
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12. Aside from the consuming the vegetable salad or the vegetable medley, would you be willing  
      to maintain your normal diet and physical activity habits during the 8-week study?   Y     N                                                                    
13. Do you follow a specific diet? (weight loss/gain, vegetarian, low-fat, etc.)    Y     N 
If yes, please explain.  
________________________________________________________________________ 
 ________________________________________________________________________ 
14. Are you able to follow this pre-visit protocol: refrain from all food and beverages including   
      alcohol, smoking, caffeine, and heaving exercise for 12 hours prior to blood draws? You will  
      be free to drink water during this period.          Y    N                                                                                                                                                                                                            
15. Please circle the total time you spend in each category for an average week. 
Light activities such as: slow walking, golf, easy swimming, gardening, etc. 
           Hours per week: 0   1   2   3   4   5   6   7   8   9   10+ 
                
Moderate activities such as: moderate walking, cycling, swimming, weight lifting, etc. 
           Hours per week: 0   1   2   3   4   5   6   7   8   9   10+ 
                 
Vigorous activities such as: fast walking, jogging, cycling, heavy/intense weight lifting,  
etc. 
           Hours per week: 0   1   2   3   4   5   6   7   8   9   10+ 
15. Please describe any other medical conditions or situations that may affect your ability to  
      participate in this research trial (i.e., infections, travel, work deadlines, etc.). 
______________________________________________________________________________ 
  
______________________________________________________________________________ 
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